BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30937134)

  • 1. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
    Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
    World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria - Results from the validation of the Polish Urticaria Control Test.
    Brzoza Z; Badura-Brzoza K; Maurer M; Hawro T; Weller K
    World Allergy Organ J; 2022 Mar; 15(3):100635. PubMed ID: 35399816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
    Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
    J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
    Maurer M; Giménez-Arnau A; Ensina LF; Chu CY; Jaumont X; Tassinari P
    World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT).
    Khoshkhui M; Weller K; Fadaee J; Maurer M; Jabbari Azad F; Emadzadeh M
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):423-431. PubMed ID: 34418896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.
    ; Yu R; Qian W; Zheng Q; Xiong J; Chen S; Chen A; Chen J; Fang S; Huang K; Cai T
    Int Arch Allergy Immunol; 2023; 184(7):643-655. PubMed ID: 36996780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q
    Ferreira PL; Gonçalo M; Ferreira JA; Costa AC; Todo-Bom A; Abreu CL; Travassos AR; Andrade P; Baiardini I; Canonica GW
    Health Qual Life Outcomes; 2019 Dec; 17(1):190. PubMed ID: 31888747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
    Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
    World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
    Kolkhir P; Laires PA; Salameh P; Asero R; Bizjak M; Košnik M; Dissemond J; van Doorn M; Hawro T; Kasperska-Zajac A; Zajac M; Kocatürk E; Peter J; Parisi CAS; Ritchie CA; Kulthanan K; Tuchinda P; Fomina D; Kovalkova E; Khoshkhui M; Kouzegaran S; Papapostolou N; Du-Thanh A; Kamegashira A; Meshkova R; Vitchuk A; Bauer A; Grattan C; Staubach P; Bouillet L; Giménez-Arnau AM; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):610-620.e5. PubMed ID: 36481420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.
    Chen Y; Yu M; Huang X; Tu P; Shi P; Maurer M; Zhao Z
    World Allergy Organ J; 2021 Jan; 14(1):100501. PubMed ID: 33510832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of chronic inducible urticaria in 423 patients: Clinical and laboratory features and comorbid conditions.
    Ornek Ozdemir S; Kuteyla Can P; Degirmentepe EN; Cure K; Singer R; Kocaturk E
    J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):513-520. PubMed ID: 37991240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Guideline Line-Care Approach to the Treatment of Chronic Inducible Urticaria.
    Sánchez J; Caraballo D; Amaya D
    J Allergy Clin Immunol Pract; 2024 May; ():. PubMed ID: 38761861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT).
    Kulthanan K; Chularojanamontri L; Tuchinda P; Rujitharanawong C; Maurer M; Weller K
    Health Qual Life Outcomes; 2016 Apr; 14():61. PubMed ID: 27075142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation and Validation of the Korean Version of the Urticaria Control Test and Its Correlation With Salivary Cortisone.
    Lee JH; Bae YJ; Lee SH; Kim SC; Lee HY; Ban GY; Shin YS; Park HS; Kratzsch J; Ye YM
    Allergy Asthma Immunol Res; 2019 Jan; 11(1):55-67. PubMed ID: 30479077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria.
    Prosty C; Gabrielli S; Mule P; Noorah N; Baum S; Greenberger S; Ensina LF; Zhang X; Netchiporouk E; Ben-Shoshan M
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3293-3298.e2. PubMed ID: 35973527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fric Test Revisited: A Suggestion for a New Scoring System and Its Correlation with Urticaria Control Test and Dermatology Life Quality Index.
    Can PK; Etikan P; Kızıltaç U; Kızıltaç K; Singer R; Kocaturk E
    Int Arch Allergy Immunol; 2019; 178(1):76-82. PubMed ID: 30286461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.
    Tawil S; Irani C; Kfoury R; Salameh P; Baiardini I; Weller K; Maurer M; Ezzedine K
    Int J Dermatol; 2020 Aug; 59(8):893-901. PubMed ID: 32638368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria.
    Ornek Ozdemir S; Can PK; Degirmentepe EN; Kızıltaç K; Singer R; Kocatürk E
    Int Arch Allergy Immunol; 2024 Jun; ():1-11. PubMed ID: 38889696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Dhabal A; Mondal H; Mondal S; Baiardini I; Chakraborty SS; Chakraborty T; Podder I
    Indian J Dermatol Venereol Leprol; 2023; 89(3):385-392. PubMed ID: 36331856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.
    Kocatürk E; Weller K; Martus P; Aktas S; Kavala M; Sarigul S; Baiardini I; Canonica GW; Brzoza Z; Kalogeromitros D; Maurer M
    Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.